188 related articles for article (PubMed ID: 34999821)
1. Inflammation and Mortality in COVID-19 Hospitalized Patients With and Without Type 2 Diabetes.
Guo J; Lin WW; Zucker JE; Nandakumar R; Uhlemann AC; Wang S; Shivakoti R
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1961-e1968. PubMed ID: 34999821
[TBL] [Abstract][Full Text] [Related]
2. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
3. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
Majeed AY; Zulkafli NES; Ad'hiah AH
Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685
[TBL] [Abstract][Full Text] [Related]
4. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG
Front Immunol; 2023; 14():1170012. PubMed ID: 37063871
[TBL] [Abstract][Full Text] [Related]
6. Temporal patterns of cytokine and injury biomarkers in hospitalized COVID-19 patients treated with methylprednisolone.
Mwangi VI; Netto RLA; de Morais CEP; Silva AS; Silva BM; Lima AB; Neves JCF; Borba MGS; Val FFAE; de Almeida ACG; Costa AG; Sampaio VS; Gardinassi LG; de Lacerda MVG; Monteiro WM; de Melo GC
Front Immunol; 2023; 14():1229611. PubMed ID: 37662953
[TBL] [Abstract][Full Text] [Related]
7. The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients.
Filgueira TO; Carvalho PRC; de Sousa Fernandes MS; Castoldi A; Teixeira AM; de Albuquerque RB; de Lima-Filho JL; Souto FO
Front Immunol; 2022; 13():1051059. PubMed ID: 36685603
[TBL] [Abstract][Full Text] [Related]
8. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.
Tripathy AS; Vishwakarma S; Trimbake D; Gurav YK; Potdar VA; Mokashi ND; Patsute SD; Kaushal H; Choudhary ML; Tilekar BN; Sarje P; Dange VS; Abraham P
Arch Virol; 2021 Dec; 166(12):3301-3310. PubMed ID: 34554303
[TBL] [Abstract][Full Text] [Related]
9. IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients.
Elbadawy HM; Khattab A; El-Agamy DS; Eltahir HM; Alhaddad A; Aljohani FD; Almuzaini TM; Abouzied MM; Aldhafiri A
J Clin Lab Anal; 2023 Apr; 37(7):e24881. PubMed ID: 37096731
[TBL] [Abstract][Full Text] [Related]
10. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients.
Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X
Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113
[TBL] [Abstract][Full Text] [Related]
11. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients.
Smail SW; Babaei E; Amin K; Abdulahad WH
Front Immunol; 2023; 14():1145840. PubMed ID: 37283736
[TBL] [Abstract][Full Text] [Related]
12. Utility of laboratory and immune biomarkers in predicting disease progression and mortality among patients with moderate to severe COVID-19 disease at a Philippine tertiary hospital.
Punzalan FER; Aherrera JAM; de Paz-Silava SLM; Mondragon AV; Malundo AFG; Tan JJE; Tantengco OAG; Quebral EPB; Uy MNAR; Lintao RCV; Dela Rosa JGL; Mercado MEP; Avenilla KC; Poblete JB; Albay AB; David-Wang AS; Alejandria MM
Front Immunol; 2023; 14():1123497. PubMed ID: 36926338
[TBL] [Abstract][Full Text] [Related]
13. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
15. Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children.
Rajamanickam A; Venkataraman A; Kumar NP; Sasidaran R; Pandiarajan AN; Selvaraj N; Mittal R; Gowshika K; Putlibai S; Lakshan Raj S; Ramanan PV; Babu S
BMC Pediatr; 2023 Apr; 23(1):156. PubMed ID: 37013538
[TBL] [Abstract][Full Text] [Related]
16. Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients.
Fabris M; Del Ben F; Sozio E; Beltrami AP; Cifù A; Bertolino G; Caponnetto F; Cotrufo M; Tascini C; Curcio F
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563218
[TBL] [Abstract][Full Text] [Related]
17. Cytokine Storm Signature in Patients with Moderate and Severe COVID-19.
Kalinina O; Golovkin A; Zaikova E; Aquino A; Bezrukikh V; Melnik O; Vasilieva E; Karonova T; Kudryavtsev I; Shlyakhto E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012146
[TBL] [Abstract][Full Text] [Related]
18. Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.
Bergamaschi C; Terpos E; Rosati M; Angel M; Bear J; Stellas D; Karaliota S; Apostolakou F; Bagratuni T; Patseas D; Gumeni S; Trougakos IP; Dimopoulos MA; Felber BK; Pavlakis GN
Cell Rep; 2021 Aug; 36(6):109504. PubMed ID: 34352226
[TBL] [Abstract][Full Text] [Related]
19. Predictive Role of Cytokine and Adipokine Panel in Hospitalized COVID-19 Patients: Evaluation of Disease Severity, Survival and Lung Sequelae.
Bergantini L; d'Alessandro M; Gangi S; Bianchi F; Cameli P; Perea B; Meocci M; Fabbri G; Marrucci S; Ederbali M; Bargagli E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629176
[TBL] [Abstract][Full Text] [Related]
20. Expression of IFN-Gamma is significantly reduced during severity of covid-19 infection in hospitalized patients.
Mansoor S; Butt AR; Bibi A; Mushtaq S; Ullah I; Alshahrani F; Khan A; Mansoor A
PLoS One; 2023; 18(9):e0291332. PubMed ID: 37756264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
